Physician

James Abbott, MD

According to 2025 Medicare claims, James Abbott, MD (NPI: 1518490283) practices dermatology in the Billings, MT market, with the plurality of this provider's patient population coming from Yellowstone, MT. This provider's primary affiliated billing organization is BILLINGS CLINIC (NPI: 1376598714; TIN: 810231784) and primary practice location at 59101-0905. Abbott is affiliated with the Billings Clinic (ACO ID: A1652) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Abbott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,992 traditional Medicare patients, billed 7,060 HCPCS/CPT codes, and received $169,591 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 613 prescription claims across 247 beneficiaries totaling $926,310 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,055 to $926,310. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$85K$170K2022 Medicare payment: $20,592 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $106,202 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $169,591 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022388710$20,592
20231,4814,161$106,202
20241,9927,060$169,591

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$463K$926K2017 Drug cost: $7,055 (USD; Tot_Drug_Cst)2018 Drug cost: $7,252 (USD; Tot_Drug_Cst)2019 Drug cost: $4,099 (USD; Tot_Drug_Cst)2020 Drug cost: $3,292 (USD; Tot_Drug_Cst)2021 Drug cost: $1,105 (USD; Tot_Drug_Cst)2022 Drug cost: $1,694 (USD; Tot_Drug_Cst)2023 Drug cost: $360,495 (USD; Tot_Drug_Cst)2024 Drug cost: $926,310 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171657$7,055
201824107$7,252
20193248$4,099
20202862$3,292
20211231$1,105
20222125$1,694
2023142273$360,495
2024247613$926,310

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more296342$42
17000Destruction of precancer skin growth, 1 growth338395$30
88305Pathology examination of tissue using a microscope, intermediate complexity1,5422,236$25
11102Biopsy of related skin growth, first growth216237$16
17003Destruction of precancer skin growth, 2-14 growths2831,886$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa161,120$321,166
Humira(Cf) PenAdalimumab24672$307,660
Dupixent PenDupilumab501,350$227,958
FluorouracilFluorouracil691,920$5,016
Clobetasol PropionateClobetasol Propionate802,184$3,379

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for James Abbott, MD?

Tedicare shows public-source Medicare data for James Abbott, MD (NPI 1518490283), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Abbott, MD have ACO affiliation data?

James Abbott, MD is shown with ACO affiliation data for Billings Clinic (MSSP, ACO ID A1652) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to James Abbott, MD?

James Abbott, MD is linked to BILLINGS CLINIC (billing NPI 1376598714) in the available physician profile data.

Does James Abbott, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.